9-ME-BC

9-ME-BC Article

9-ME-BC (9-Methyl-beta-carboline) Research Standard

9-ME-BC (9-Methyl-beta-carboline) is a heterocyclic amine derivative belonging to the beta-carboline family. Within the field of neuropharmacology, it is an investigative compound characterized by its potential dopaminergic and neurotrophic properties. Researchers utilize 9-ME-BC as a pharmacological probe to study pathways involved in neuroprotection, the stimulation of neurite outgrowth, and the enhancement of dopaminergic signaling in controlled in vitro and animal models.

Technical Specifications

Mechanism of Action & Research Context

9-ME-BC is primarily investigated for its effects on the dopaminergic system and its potential neuro-regenerative influence, as detailed in established scientific literature.

• Neurite Outgrowth and TH Expression: 9-ME-BC is notably researched for its neurotrophic properties. Foundational studies by Gille et al. (2011) demonstrated that the compound stimulates neurite outgrowth and increases the expression of tyrosine hydroxylase (TH)—the rate-limiting enzyme in dopamine synthesis—in cultured mesencephalic dopaminergic neurons.

• Neuroprotective Mechanisms: Research into the compound’s neuroprotective capacity indicates it may mitigate dopaminergic degeneration. Studies by Polanski et al. (2010) evaluated the compound’s ability to provide protection against neurotoxic insults in cellular models, suggesting a role in maintaining dopaminergic neuronal integrity under stress.

• Cognitive and Behavioral Research: Investigations into the compound’s potential effects on higher-order function have utilized animal models. Research by Gille et al. (2013) observed improvements in spatial learning and memory following administration, hypothesizing that 9-ME-BC may modulate synaptic connectivity pathways.

Research Applications

9-ME-BC is a specialized reagent essential for modern neuroscience and neuro-degenerative research.

Primary fields of in vitro and laboratory investigation include:

• Neuroprotection Studies: Assessing the ability of the compound to rescue dopaminergic neurons from neurotoxin-induced damage in cellular models.

• Neurite Outgrowth Analysis: Quantifying the effect of 9-ME-BC on axonal and dendritic extension in cultured primary neurons.

• Dopaminergic Signaling: Benchmarking the compound’s efficacy in modulating dopamine synthesis and turnover rates.

• Cognitive Enhancement Models: Utilizing animal models to observe the impact of 9-ME-BC on memory, learning, and synaptic connectivity pathways.

Storage & Handling Guidelines

To maintain the chemical stability and experimental reliability of the compound:

• Storage Environment: Store in a cool, dry place. Maintain at -20°C for long-term stability.

• Environmental Control: Protect strictly from light, moisture, and high temperatures to prevent oxidation and degradation of the beta-carboline scaffold.

• Handling: Utilize standard laboratory safety practices. Allow the container to equilibrate to room temperature before opening to minimize condensation.

• Aseptic Technique: Ensure the use of sterile laboratory tools to prevent cross-contamination during preparation of solutions for in vitro experiments.

Research Use Disclaimer

Research Use Only Disclaimer: This product is developed and distributed strictly as a Research Use Only (RUO) laboratory reference chemical intended exclusively for non-clinical analytical and scientific investigation. It is not an FDA-approved drug, medical treatment, dietary supplement, or food ingredient, and is strictly prohibited for human or animal consumption. Kimera Chems supplies this high-purity research material solely to qualified institutions and professional investigators for authorized laboratory research.